Spineguard (France) Performance
| ALSGD Stock | EUR 0.15 0.01 6.25% |
The entity has a beta of 0.27, which indicates not very significant fluctuations relative to the market. As returns on the market increase, Spineguard's returns are expected to increase less than the market. However, during the bear market, the loss of holding Spineguard is expected to be smaller as well. At this point, Spineguard has a negative expected return of -0.47%. Please make sure to validate Spineguard's information ratio, kurtosis, period momentum indicator, as well as the relationship between the treynor ratio and day median price , to decide if Spineguard performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Spineguard has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 1.2 M | |
| Total Cashflows From Investing Activities | -367.6 K |
Spineguard |
Spineguard Relative Risk vs. Return Landscape
If you would invest 21.00 in Spineguard on December 19, 2024 and sell it today you would lose (6.00) from holding Spineguard or give up 28.57% of portfolio value over 90 days. Spineguard is generating negative expected returns and assumes 4.1008% volatility on return distribution over the 90 days horizon. Simply put, 36% of stocks are less volatile than Spineguard, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Spineguard Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Spineguard's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Spineguard, and traders can use it to determine the average amount a Spineguard's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1144
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALSGD |
Estimated Market Risk
| 4.1 actual daily | 36 64% of assets are more volatile |
Expected Return
| -0.47 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Spineguard is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Spineguard by adding Spineguard to a well-diversified portfolio.
Spineguard Fundamentals Growth
Spineguard Stock prices reflect investors' perceptions of the future prospects and financial health of Spineguard, and Spineguard fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Spineguard Stock performance.
| Return On Equity | -0.43 | |||
| Return On Asset | -0.082 | |||
| Profit Margin | (0.44) % | |||
| Operating Margin | (0.33) % | |||
| Current Valuation | 18.77 M | |||
| Shares Outstanding | 31.71 M | |||
| Price To Earning | (4.81) X | |||
| Price To Book | 3.68 X | |||
| Price To Sales | 4.11 X | |||
| Revenue | 4.41 M | |||
| EBITDA | (812.46 K) | |||
| Cash And Equivalents | 1.06 M | |||
| Cash Per Share | 0.16 X | |||
| Total Debt | 3.61 M | |||
| Debt To Equity | 567.90 % | |||
| Book Value Per Share | 0.16 X | |||
| Cash Flow From Operations | (1.16 M) | |||
| Earnings Per Share | (0.08) X | |||
| Total Asset | 11.9 M | |||
About Spineguard Performance
Assessing Spineguard's fundamental ratios provides investors with valuable insights into Spineguard's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Spineguard is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
The companys PediGuard products are handheld devices that detect possible vertebral cortex perforation during pedicle preparation for screw placement, and alerts surgeons prior to a breach by analyzing the electrical conductivity of the surrounding tissues in real time. SpineGuard SA was founded in 2009 and is headquartered in Vincennes, France. SPINEGUARD operates under Medical Devices classification in France and is traded on Paris Stock Exchange. It employs 19 people.Things to note about Spineguard performance evaluation
Checking the ongoing alerts about Spineguard for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Spineguard help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Spineguard generated a negative expected return over the last 90 days | |
| Spineguard has some characteristics of a very speculative penny stock | |
| Spineguard has high historical volatility and very poor performance | |
| Spineguard has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 4.41 M. Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 3.61 M. | |
| Spineguard has accumulated about 1.06 M in cash with (1.16 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.16, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
- Analyzing Spineguard's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Spineguard's stock is overvalued or undervalued compared to its peers.
- Examining Spineguard's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Spineguard's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Spineguard's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Spineguard's stock. These opinions can provide insight into Spineguard's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Spineguard Stock Analysis
When running Spineguard's price analysis, check to measure Spineguard's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Spineguard is operating at the current time. Most of Spineguard's value examination focuses on studying past and present price action to predict the probability of Spineguard's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Spineguard's price. Additionally, you may evaluate how the addition of Spineguard to your portfolios can decrease your overall portfolio volatility.